Talaris Therapeutics – phase 3 biotech Talaris Therapeutics sets terms for $150 million IPO.
- Detailed instructions how to participate in Talaris (pre-IPO, offering price) see below👇
What is an IPO and how it works
IPO is a process of offering shares of a private corporation to the public in a new stock issuance. Why go public? The primary benefit of going public is easier access to capital.
To go public, a company must have a track record of growth and other favorable results and hire an investment bank to come in and underwrite the IPO (Morgan Stanley, SVB Leerink, Evercore ISI, Guggenheim Securities in Talaris case). The underwriters also performed due diligence and verified financial information and business model.
Once the paperwork done, the company sells the stock to institutional investors. When the initial block of shares has been sold, the company with underwriters' help sets an initial price and date for the stock to begin trading on a stock exchange.
Company Profile and Financial Indicators before Talaris IPO
Talaris Therapeutics is launching its IPO in the NASDAQ on May 6. The company is focused on developing an innovative method for allogeneic hematopoietic stem cell transplantation (allo-HSCT). This can help with organ transplantation for patients suffering from severe autoimmune diseases, benign blood diseases, and immune and metabolic disorders.
Three of Talaris Therapeutics' four products are currently undergoing clinical trials.The company's flagship asset, FCR001, is a special type of allo-HSCT cell therapy for patients who receive kidney transplants from living donors. The product has successfully passed stage two clinical trials, and the studies have shown that 70% of patients who have received a kidney transplant from a living donor can stop using immunosuppressant agents. Meanwhile, changing treatment tactics in the middle of the course helped 82% of clinical trial participants stop using immunosuppressants. Talaris Therapeutics is currently recruiting participants for stage three of the trials, FREEDOM-1.
Talaris Therapeutics was founded in 2018 by Dr. Suzanne Ildstad. The new therapeutic approach is based on her research at the Institute of Cell Therapy, University of Louisville. Since its inception, the company raised $215M, the shareholders including Blackstone, Longitude Venture Partners III, Qiming, Citadel Multi-Strategy Equities Master Fund Ltd, and Viking Global Opportunities Illiquid Investments Sub-Master LP.
Talaris Therapeutics has no off-the-shelf products or grant revenues, so the company has no revenue. For 2020, its cumulative loss was $ 22.7 million.
The company has 4 developments. 3 are in clinical trials.
8.8 million shares will be offered for placement.
The volume of funds raised will be $ 150 million, while the company is estimated at about $ 681.6 million.
How to Buy Talaris Stocks Before the IPO (Offering Price)
In the past, IPOs as highly profitable investments were available only to the privileged customers of the leading brokerage firms and it was challenging for retail investors to gain access. You couldn't buy shares paying the price set by the company and you had to wait until the shares actually start trading on the public stock market at whatever stock price supply and demand allows.
Technologies and marketplaces changed the rules of the game, now regular investors can get pre-IPO shares. To participate in Talaris IPO you need to use an IPO investing app like Freedom Finance (NASDAQ: FRHC), TD Ameritrade or Fidelity. They give its customers access to IPOs and secondary offerings through their existing brokerage account. Also you can buy Talaris shares when the company goes public via a commission-free trading app like eToro.
🚨 Detailed Instructions How to Participate in the Talaris IPO before public trading:
Below we share the instruction how to participate in the approaching Talaris IPO using Freedom Finance (Freedom24 platform). This marketplace is chosen as an example because Talaris is already listed there.
* Freedom Finance services are NOT available to US citizens and residents.
- Apply for a Freedom Finance account — you need to prepare your identity document and a document confirming the address of residence (utility bill). The verification process is very fast, it will take 2 minutes to create your account.
- Deposit your account — to participate in an IPO, your account must have available funds in the amount you send IPO application for.
- 💡 Tip: It's recommended to deposit your account in advance. Often the exact IPO date is undefined until the last day. You may have a short notice for participation and account deposits also takes time for processing. Also, sometimes Freedom sends last-minute IPO offer when you have 2 hours to participate.
- Submit a request to participate in the IPO — when applications are open select Talaris and click Participate in the IPO > input the amount you want to invest > Send your application. Note: Before the book closing, a request can be withdrawn. At the time of the book closing, 1 day before the start of the exchange trading, the specified amount will be blocked on the account.
- Wait for allocation — The actual number of stocks purchased during an IPO depends on supply and demand. The higher underwriter reserves the right to partial execution of collective applications. So if the demand is high you may get less than you applied for. Of course, you will only pay for the shares purchased. The rest of the funds will be returned to your account.
- Start of trading — With the beginning of the public trading on the stock exchange, the purchased shares will appear on the account and a lock-up period will start — a 93-day period of prohibition on sale. You can’t sell stocks, but you can track their current value and growth indicators in your personal member area and a trading terminal.
- Closing your trade — At the end of the 93 days lock-up period, you will be able to manage your stocks at your discretion — leave in the portfolio or sell and withdraw money or transfer the stocks to another depository/ broker in your name. This can be done in your account by clicking the ‘Sell’ button next to the name of the security. In this case, a commission of 0.5% of the amount of the sale transaction is charged.
Is investing in IPOs profitable?
Not always. The average return at the end of the lock-up period is 72%, past IPOs data.
When is the Talaris IPO date?
May 7, 2021
What is Talaris IPO price range?
$16 - $18 per share
How to Invest in Talaris after the IPO date (opening price)?
In what currency Talaris IPO and post-IPO shares will be traded?
The Talaris IPO and stock trading currency will be USD.
If you have funds in another currency the cheapest way to convert your currency is to use the mid-market rate (that’s the one you’ll find on Google) which can be done via a fintech service like Wise. Banks may add hidden markups to their exchange rates - charging you more without your knowledge. And if they have a fee, they charge you twice. Wise never hides fees in the exchange rate.
Talking about currency exchange – if you need to buy crypto the best and cheapest way to do it on the largest cryptocurrency exchange in the world - Binance. If you don't have an account yet, here you can create a free account with 5% cashback over every trade you do.
What is the Talaris (stock symbol)
The stock ticker for Talaris will be TALS
Talaris Registration Statement on Form S-1
This page may contain affiliate links.